Rare diseases
Investigational molecules
Locations
1209 North Orange Street, 19801-1120, United States
Corxel Pharmaceuticals Inc. is focused on clinical research in Type 2 Diabetes Mellitus, with attention to glycaemic control and the management of HbA1c as a key marker of long-term metabolic status.
The sponsor’s current clinical activity is centred on therapeutic development for patients with metabolic disease in the United States.
Corxel Pharmaceuticals Inc. runs clinical trials in conditions such as Type 2 diabetes mellitus, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
A study to evaluate the effect of CX11 trometamol monohydrate in patients with type 2 diabetes
PolandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
